Aug 05, 2021 09:27 PM (GMT+8) · EqualOcean
Warner pharmaceutical announced that yesterday, the company considered and approved the proposal on using part of the raised funds to provide interest free loans to wholly-owned subsidiaries to implement raised investment projects. The company added a wholly-owned subsidiary, Hunan Warner Da pharmaceutical chiral drugs Co., Ltd. ("chiral drugs company") as the implementation subject of the raised investment project "drug R & D project", It is agreed to provide an interest free loan with a total amount of no more than 43 million yuan to chiral drug companies for the implementation of "drug R & D projects".